1 / 15

Pathophysiology: 病理生理学

The involvement of G proteins and regulators of receptor–G protein coupling in the pathophysiology, diagnosis and treatment of mood disorders. Pathophysiology: 病理生理学. Mood disorder. 单极情绪紊乱 如抑郁症 ,狂躁症等 多极情绪紊乱( bipolar mood disorder )躁狂发作 (manicepisode) 与忧郁发作 (depressiveepisode) 交互或混合地出现.

fergal
Download Presentation

Pathophysiology: 病理生理学

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The involvement of G proteins and regulators of receptor–G protein coupling in the pathophysiology, diagnosis and treatment of mood disorders Pathophysiology:病理生理学

  2. Mood disorder • 单极情绪紊乱 如抑郁症 ,狂躁症等 • 多极情绪紊乱(bipolar mood disorder )躁狂发作(manicepisode)与忧郁发作(depressiveepisode)交互或混合地出现

  3. Biochemical research in mood disorders has focused, along the cascade of events involved in signal transduction, from studies at the level of the monoamine neurotransmitter to the level of the neurotransmitter receptors, and lately to information transduction mechanisms beyond receptors, involving the coupling of receptors with signal transducers.

  4. Research level • Momoamine neurotrotransmitter 第一信使水平 • Neurotrotransmitter recepter 膜受体水平 • information transduction mechanisms beyond receptors 第二信使水平

  5. The “pharmacological bridge” approach to the construction of pathogenic hypotheses for mood disorders The pharmacological bridge approach to the construction of biological hypotheses for the pathogenesis of mental disorders is trying to induce from knowledge and hypotheses concerning the biochemical mechanisms of action ofneuro-psychiatric medications to pathogenic and pathophysiological hypotheses,e.g. dopamine ------------- schizophrenia monoamine -------------mood disorders.

  6. 治疗药物——降低生物胺水平——降血压——抗狂躁;治疗药物——提高生物胺的功能性——抗抑郁治疗药物——降低生物胺水平——降血压——抗狂躁;治疗药物——提高生物胺的功能性——抗抑郁 • First,reserpine(利血平),a medication that decreasesblood pressure by depleting biogenic amine stores, wasknown to precipitate clinical depression in some patients • Second, antidepressant medications(抗抑郁药物), which alleviate clinical depression, were found to raise the functional capacity ofthe biogenic amines in the brain.

  7. monoamine oxidase A (MAO-A) A mitochondrial enzyme that plays an important role in degradative deamination(去胺化) of several differentamines, including serotonin(血液复合胺), norepinephrine(去甲肾上腺素)anddopamine

  8. The involvement of receptor signal transducers-G proteins in the pathophysiology and treatment of mood disorders Lithium (Li) inhibition of beta-adrenergic receptor coupled G proteins’ function was suggested as a single molecular site for antidepressant therapeutic effects of this ion . Lithium’s molecular mechanism of interaction with G proteins was found to involve competition with magnesium(Mg) ions on magnesium low-affinity sites (Mg低亲和位点)essential for guanine nucleotide (鸟苷酸)exchange on these proteins (activation of G proteins by guanine nucleotides . (G protion level,mRNA level)

  9. 鸟苷酸结合蛋白(guanine nucleotide-binding regulatory protein),简称G蛋白 . 第二信使学说,其主要内容包括:①激素是第一信使,它可与靶细胞膜上具有立体构型的专一性受体结合;②激素与受体结合后,激活漠上的腺苷酸环化酶系统;③在mg2+存在的条件下,腺苷酸环化酶促使ATP转变为cAMP,cAMP是第二信使,信息由第一信使传递给第二信使;④cAMP是使无活性的蛋白激酶(PKA)激活。

  10. Subsequent studies have shown that lithium decreased the levels of mRNA for the alpha subunits of Gs, Gi and Go proteins . Measuring G protein function through agonist (serotonin血液中的复合胺) enhanced guanine nucleotide binding in rat cortical(脑皮层) membranes, lithium was found to interfere with receptor–G protein (Gs, Gi and Go) coupling via a magnesium-sensitive mechanism .

  11. G protein-coupled receptor kinases (GRKs) Using a functional genomic approach a series of candidate genes involved in the pathogenesis of mood disorders was identified including G protein-coupled receptor kinase 3 (GRK3), which was also found to be decreased in lymphoblastoid cell(淋巴母细胞)lines from a subset of bipolar patients .

  12. More recently a single nucleotide polymorphism(SNP单核苷多态现象) in the promoter region of GRK3 was found to be associated with bipolar disorder. The findingsconcerning GRK3 gene are in accord with evidence from genome-wide linkage survey suggesting that the chromosome 22q12 (22号染色体长臂1区2带)region contains a susceptibility locus (易感情化区)for bipolar disorder.

  13. 单核苷酸多态性(SNP)是指在基因组上单个核苷酸的变异,包括置换、颠换、缺失和插入。从理论上来看每一个SNP 位点都可以有4 种不同的变异形式,但实际上发生的只有两种,即转换和颠换,二者之比为2 :1。SNP 在CG序列上出现最为频繁,而且多是C转换为T ,原因是CG中的C 常为甲基化的,自发地脱氨后即成为胸腺嘧啶。一般而言,SNP 是指变异频率大于1 %的单核苷酸变异。在人类基因组中大概每1000 个碱基就有一个SNP ,人类基因组上的SNP 总量大概是3 ×106 个 。

  14. Membrane-associated GRK 2/3 was found to be increased in specimens of postmortem prefrontalcortices collected from depressed patients.Acutetreatment (1–6 h) with the tricyclic antidepressant desipramine(脱甲丙咪嗪,抗抑郁药), increased membrane-associated GRK 2/3 in rat brain. This effect vanished(消失) with aprolonged desipramine exposure(延长处理时间)(24h–14days) .

  15. Major depression was found to be associated with reduced platelet(血小板)GRK 2, while treatment with mirtazapine(米尔塔扎平,抗抑郁药) reversed(颠倒)this abnormality .

More Related